Background: The incidence of fungal infections have increased in recent decades, particularly due to the increase in the immunocompromised population. Opportunistic fungal infections were identified as significant causes of mortality and morbidity in this population. In addition, multidrug resistance (MDR) patterns detected in fungal species limit the efficacy of antifungals. Photodynamic inactivation was identified as a novel antimicrobial method of treatment with increased interest towards 5-Aminolevulinic acid (5-ALA). It was found that when metabolized to Protoporphyrin IX (PpIX), a photosensitizing agent, irradiated with light, membrane damage was detected.
